S.P. Medicines Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 27-12-2024
- Paid Up Capital ₹ 1.50 M
as on 27-12-2024
- Company Age 22 Year, 26 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.00 M
as on 27-12-2024
- Revenue -18.93%
(FY 2021)
- Profit -47.61%
(FY 2021)
- Ebitda -35.84%
(FY 2021)
- Net Worth 6.08%
(FY 2021)
- Total Assets -14.81%
(FY 2021)
About S.P. Medicines
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹8.00 M.
Sukumar Panda, Suvayu Panda, Palima Panda, and One other member serve as directors at the Company.
- CIN/LLPIN
U24239WB2002PTC095515
- Company No.
095515
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Dec 2002
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Medinipur, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at S.P. Medicines?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sukumar Panda  | Managing Director | 16-Dec-2002 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Suvayu Panda | Director | 16-Dec-2002 | Current |
| Palima Panda | Director | 16-Dec-2002 | Current |
| Paramita Panda | Whole-Time Director | 26-Oct-2017 | Current |
Financial Performance of S.P. Medicines.
S.P. Medicines Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 18.93% decrease. The company also saw a substantial fall in profitability, with a 47.61% decrease in profit. The company's net worth moved up by a moderate rise of 6.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of S.P. Medicines?
Unlock access to S.P. Medicines's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 07 Sep 2006 | ₹8.00 M | Open |
How Many Employees Work at S.P. Medicines?
Unlock and access historical data on people associated with S.P. Medicines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of S.P. Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped S.P. Medicines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
